WebNov 23, 2024 · The transcription factor FOXM1 that regulates multiple proliferation-related genes through selective protein-DNA and protein–protein interactions is now considered an attractive oncotarget. There are several small-molecule inhibitors that indirectly suppress the expression of FOXM1 or block its DNA binding domain (FOXM1-DBD). However, … WebJun 19, 2024 · As a master transcriptional regulator, FOXM1 promotes critical oncogenic phenotypes in ovarian cancer, including: (1) cell proliferation, (2) invasion and …
FOXM1 binds directly to non-consensus sequences in the …
WebOur FOXM1 polyclonal, monoclonal, recombinant monoclonal and recombinant polyclonal antibodies are developed in Rabbit and Mouse. These antibodies have been verified by Knockdown and Cell treatment to confirm specificity to FOXM1. Find the FOXM1 antibody that fits your needs. Choose from 1 of 29 FOXM1 antibodies, which have been validated … WebJul 14, 2024 · FOXM1 transcription factor is an oncogene and a master regulator of chemoresistance in multiple cancers. Pharmacological inhibition of FOXM1 is a promising approach but has proven to be... lawyers edmonds wa
JCI - FOXM1 is a critical driver of lung fibroblast activation and ...
WebNov 1, 2014 · FOXM1 regulates the transcription of a multitude of genes essential for DNA damage response. NER functions to remove and replace bulky helix-distorting base lesions, such as pyrimidine dimers [21], [39], [40].The correct DNA structure is restored through gap-filling and religation by replication factor C (RFC), proliferating cell nuclear antigen … WebApr 12, 2024 · There is an increasing understanding of the molecular and cytogenetic background of various tumors that helps us better conceptualize the pathogenesis of specific diseases. Additionally, in many cases, these molecular and cytogenetic alterations have diagnostic, prognostic, and/or therapeutic applications that are heavily used in clinical … WebApr 9, 2024 · Author summary Idiopathic pulmonary fibrosis (IPF) is a severe chronic lung disease, which is refractory to treatment. The environmental, age-related, and genetic factors increase susceptibility of the lung to injury. Repeated injury and deregulated repair result in scarring of the lung tissue and ultimate loss of respiratory function. … lawyers edition abbreviation